Boothbay Fund Management’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,731
Closed -$29.5K 1651
2025
Q1
$29.5K Hold
13,731
﹤0.01% 1313
2024
Q4
$53.1K Sell
13,731
-2
-0% -$13 ﹤0.01% 1349
2024
Q3
$90K Sell
13,733
-62,179
-82% -$500K ﹤0.01% 1466
2024
Q2
$550K Sell
75,912
-26,982
-26% -$207K 0.01% 961
2024
Q1
$781K Sell
102,894
-27,064
-21% -$211K 0.02% 840
2023
Q4
$591K Sell
129,958
-17,245
-12% -$58.2K 0.02% 924
2023
Q3
$581K Buy
+147,203
New +$557K 0.01% 969
2023
Q2
Sell
-23,468
Closed -$106K 2077
2023
Q1
$106K Buy
23,468
+4,047
+21% +$21.1K ﹤0.01% 1913
2022
Q4
$80.2K Buy
+19,421
New +$66.3K ﹤0.01% 1838
2021
Q3
Sell
-10,163
Closed -$100K 2066
2021
Q2
$100K Sell
10,163
-37,870
-79% -$428K ﹤0.01% 1739
2021
Q1
$702K Buy
+48,033
New +$873K 0.03% 767

Other funds holding LRMR